![](/img/cover-not-exists.png)
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value
Garantziotis, SVolume:
104
Year:
2011
Language:
english
Pages:
1
DOI:
10.1038/sj.bjc.6606068
File:
PDF, 73 KB
english, 2011